Waltham biotech Checkpoint Therapeutics stops cancer study due to Ukraine war
A Waltham biotech is stopping a late-stage clinical trial of a cancer drug because of the ongoing war in Ukraine.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Rowan Walrath Source Type: news
More News: American Health | Biotechnology | Cancer | Cancer & Oncology | Clinical Trials | Health Management | Study | Ukraine Health